SOTAC PHARMACEUTICALS
Back to Cashflow Statement
|
SOTAC PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-4.33 Cr | ₹-16 Cr | ₹8.14 Cr | ₹6.35 Cr | ₹-0.31 Cr |
What is the latest Cash Flow from Operating Activities ratio of SOTAC PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-4.33 Cr |
| Mar2024 | ₹-16 Cr |
| Mar2023 | ₹8.14 Cr |
| Mar2022 | ₹6.35 Cr |
| Mar2021 | ₹-0.31 Cr |
How is Cash Flow from Operating Activities of SOTAC PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-4.33 Cr | Negative | |
| Mar2024 | ₹-16 Cr | Negative | |
| Mar2023 | ₹8.14 Cr | 28.22 | |
| Mar2022 | ₹6.35 Cr | Positive | |
| Mar2021 | ₹-0.31 Cr | - | |
Compare Cash Flow from Operating Activities of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹97.0 Cr | -12.6% | -21.4% | -24% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -12.6% |
-21.4% |
-24% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses